IN8BIO, Inc. SEC filings INAB

IN8BIO, Inc. has 410 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

IN8BIO, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Agreement ended
Jun 1, 2026 May 29, 2026
424B5 Prospectus supplement Jun 1, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 29, 2026 —
4 Insider transaction May 29, 2026 May 27, 2026
EFFECT Filing May 19, 2026 —
S-3/A Filing May 18, 2026 —
CORRESP Letter to the SEC May 15, 2026 —
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
4 Insider transaction May 12, 2026 May 9, 2026
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 Employee stock plan registration May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Officer or director change, Shareholder vote results
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Mar 26, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 26, 2026 —
DEF 14A Proxy statement Mar 26, 2026 May 7, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 2, 2026 —
8-K Current report
Officer or director change
Feb 27, 2026 Feb 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Officer or director change
Feb 9, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
424B3 Prospectus Jan 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 29, 2026 —
EFFECT Filing Jan 28, 2026 —
UPLOAD Letter from the SEC Jan 27, 2026 —
CORRESP Letter to the SEC Jan 26, 2026 —
S-3 Shelf registration Jan 20, 2026 —
SCHEDULE 13D Ownership over 5% (active) Jan 2, 2026 —
D Filing Dec 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 30, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 29, 2025 —
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 22, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2025 Dec 18, 2025
8-K Current report
Other events
Nov 24, 2025 Nov 21, 2025
S-3 Shelf registration Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
8-K Current report
Other events
Jun 30, 2025 Jun 24, 2025
8-K Current report
Change to shareholder rights
Jun 4, 2025 Jun 3, 2025
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
8-K Current report
Shareholder vote results
May 9, 2025 May 8, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 8, 2025 —
4 Insider transaction May 7, 2025 May 2, 2025
4 Insider transaction May 7, 2025 May 2, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
4 Insider transaction May 7, 2025 Apr 27, 2025
10-K/A Amended annual report May 7, 2025 Dec 31, 2024
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
DEFR14A Filing Apr 29, 2025 —
8-K Current report
Other events
Apr 28, 2025 Apr 28, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Apr 28, 2025 Apr 27, 2025
ARS Annual report to shareholders Mar 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 17, 2025 —
DEF 14A Proxy statement Mar 17, 2025 May 8, 2025
S-8 Employee stock plan registration Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
PRE 14A Preliminary proxy statement Mar 5, 2025 May 8, 2025
8-K Current report
Officer or director change
Mar 5, 2025 Mar 4, 2025
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
8-K Current report
Listing notice
Feb 7, 2025 Feb 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 31, 2025 —
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
4 Insider transaction Dec 23, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Other events
Nov 25, 2024 Nov 25, 2024
EFFECT Filing Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
CORRESP Letter to the SEC Nov 8, 2024 —
UPLOAD Letter from the SEC Nov 7, 2024 —
S-3 Shelf registration Nov 4, 2024 —
D Filing Oct 15, 2024 —
4 Insider transaction Oct 11, 2024 Oct 4, 2024
4 Insider transaction Oct 11, 2024 Oct 4, 2024
SC 13D/A Amended ownership over 5% (active) Oct 11, 2024 —
SC 13G Ownership over 5% (passive) Oct 9, 2024 —
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Oct 1, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Sep 17, 2024 —
8-K Current report
Officer or director change
Sep 11, 2024 Sep 6, 2024
8-K Current report
Officer or director change
Sep 6, 2024 Aug 30, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
8-K Current report
Exit or restructuring costs, Other events
Sep 4, 2024 Aug 30, 2024
424B5 Prospectus supplement Aug 12, 2024 —
8-K Current report
Other events
Aug 12, 2024 Aug 12, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
8-K Current report
Shareholder vote results, Other events
Jun 13, 2024 Jun 12, 2024
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
424B5 Prospectus supplement May 7, 2024 —
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 12, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
S-8 Employee stock plan registration Jan 19, 2024 —
EFFECT Filing Jan 18, 2024 —
424B3 Prospectus Jan 18, 2024 —
CORRESP Letter to the SEC Jan 16, 2024 —
UPLOAD Letter from the SEC Jan 16, 2024 —
S-3 Shelf registration Jan 12, 2024 —
D Filing Dec 28, 2023 —
SC 13G/A Amended ownership over 5% (passive) Dec 15, 2023 —
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
INAB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1740279
Former names
Incysus Therapeutics, Inc. (until Sep 20, 2018)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.